Category: pharma & healthcare

New SARS-CoV-2 Variant BA.2.75 Evades All Approved Monoclonal Antibody Therapies

The latest in the Omicron family of variants, BA.2.75, is more resistant to monoclonal antibodies than its predecessors, posing problems for treating Covid-19.

Mild Covid Inflicts Paradoxical Brain Damage: Detected By Imaging But Not By Neuropsychological Assessment

This study identifies SARS-CoV-2 damage to the white matter of the brain; paradoxically, the structural changes were not associated with worse neuropsychiatric scores.

Arthritis Patients Are Being Denied Methotrexate Post-Dobbs. Are People With Cancer Next?

Methotrexate is an important therapy for cancer and some oncologists are concerned about the potential knock-on effect of the supreme court decision on patients.

Are Chronic Infections Responsible For SARS-CoV-2 Variants?

Most SARS-CoV-2 infections are cleared within a week or two, but it is not always the case. Immunocompromised individuals are susceptible to month- or even year-long infections, known as chronic infections. A growing body of research suggests they may …

Should You Get Vaccinated For Covid-19? Yes. Will It Protect You From Long Covid? Probably Not.

Current covid-19 vaccines prevent hospitalization and death—do they also prevent Long Covid? A study published in The Journal of the American Medical Association confirms an existing observation: that vaccination provides little protection against deve…

Robotic Arms Allow Partially Paralyzed Man To Feed Himself

Thanks to the work of scientists at Johns Hopkins University, a partially paralyzed man was able to feed himself for the first time in thirty years using just his mind and a pair of robotic arms.

More Danger Ahead With BA.5: Covid-19 Reinfection Doubles The Risk For Death, Blood Clots, And Lung Damage

A recent preprint concludes that two or more Covid-19 reinfections double the risk for death, blood clots, and lung damage among other negative health outcomes, demonstrating the clear and present danger of reinfection.

Pasteur Institute Scientists Discover SARS-CoV-2 Broadly-Neutralizing Antibody

Here we examine a new monoclonal antibody candidate that neutralizes Omicron BA.1 and BA.2, as well as all variants that came before.

Long Covid And Its Unequal Burden

The heightened probability of infection, reduced access to primary/specialized care, and diminished economic position faced by minority populations will translate to a more arduous road to Long Covid recovery.

BA.2.75: A Dark Horse In The Covid Pandemic

The BA.2.75 variant is the latest in a long line of Omicron variants. It is a dark horse candidate to be the worst one yet.